Overview

Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)

Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
To evaluate Quality of Life (QoL) score of MS-20 versus placebo in advanced HCC patients using European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30 questionnaire.
Phase:
Phase 2
Details
Lead Sponsor:
Microbio Co Ltd